Refine by
Laboratory Technology Articles & Analysis
28 news found
Nanotechnology has unlocked groundbreaking advancements in drug delivery, disease diagnostics and laboratory technologies by synthesizing and manipulating substances at the nanoscale. However, industry and research laboratories face challenges in analyzing complex and diverse samples and require sensitive and reliable drug delivery systems to ...
With a focus on cutting-edge technology and a team of expert professionals, Creative Enzymes is spearheading the discovery of novel enzymes with diverse applications across various industries. ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, aims to enhance cell culture results by providing researchers and laboratories with a variety of simple and high-performance 3D cell culture systems. ...
Dave Kunelius, President of MedSource Labs, recently addressed the Honorable Katherine Tai, United States Trade Representative, as part of an ongoing dialogue with local and national policymakers concerning challenges in the medical supply chain. In his communication dated April 19, 2024, Kunelius emphasized MedSource Labs’ role in manufacturing essential medical devices, such as IV ...
THE KIT OFFERS A COMPLETE WORKFLOW SOLUTION TO ENABLE LABORATORIES WITH NGS CAPABILITIES TO SUPPORT ONCOLOGISTS IN FINDING THE MOST EFFECTIVE AND PERSONALIZED TREATMENTS FOR THEIR CANCER PATIENTS. ...
"MerLion Pharmaceuticals is in particular looking forward to continuing the collaboration with its partners from the UK's Defence Science and Technology Laboratory (Dstl). The success of this collaboration has been and will continue to be instrumental in establishing finafloxacin as a treatment against B. pseudomallei infections, and wouldn’t have been ...
Proximie, the global health technology platform that helps save lives by digitising operating rooms and cath. labs leveraging technologies including Augmented Reality (AR) and Artificial Intelligence (AI), appoints Scott Huennekens as an advisor to CEO and the Board of Directors. Scott is a successful MedTech CEO, Chairman, board member, entrepreneur and investor, having been involved in over 20 ...
“While OncoDEEP has been our flagship biomarker test over the past years, we see more and more laboratories adopting NGS technology and becoming interested in utilizing our test in-house. ...
AcuPebble SA100 is clinically equivalent to cardiorespiratory polygraphy for the automated diagnosis of obstructive sleep apnea (OSA) at home, a paper published in the BMJ Open has revealed. A powered clinical trial conducted by the Royal Free Hospital in London demonstrated both the accuracy and usability of the small device, which has the potential to open more efficient patient pathways for ...
Theramx Corporation announced on the 18th that it would promote the listing on KONEX with the will to properly evaluate the company's value through listing on the occasion of the completion of the recent export of 'EG-Q' to Europe. Theramx, which has a GMP production facility in Seongnam, Gyeonggi-do and its own research center in Uiwang, Gyeonggi-do, is focusing on developing a nano-bio ...
TearLab Corporation, a global ophthalmic diagnostics company marketing point-of-care laboratory testing, today announced that Adam Szaronos has been appointed President and Chief Executive Officer by the company's Board of Directors, effective immediately. ...
BySOFIE
AcuPebble SA100, a small wearable device that enables automated, remote home testing to detect obstructive sleep apnoea (OSA) in adults, has obtained FDA 510(k) clearance as a Class II medical device in the USA. The device, which received a CE Mark as a Class IIa medical device in 2020, was developed and is commercialised by UK-based medical device company Acurable and builds on more than ten ...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it has been named to Fast Company’s inaugural Next Big Things in Tech list, honoring the technology breakthroughs that promise to shape the future of their industries — from healthcare to ...
Marizyme Inc. (“Marizyme” or the “Company”) (OTCQB:MRZM), is pleased to announce the hiring of Mr. David Barthel as the Chief Executive Officer for Marizyme. In his role Mr. Barthel will look to advance the Company’s technology pipeline and stay committed to the commercialization efforts of DuraGraft in Europe and Asia while focusing on the FDA submissions for ...
Gamidor provides systems, reagents and services to clinical laboratories, hospitals and academic research institutions in Israel, and represents world-leading diagnostics companies, including Roche Diagnostics. "The world of laboratory instrumentation is undergoing a revolution to mobile point-of-care (POC) devices located at the patient's bedside. ...
"We identified PixCell Medical as a company proven to have disruptive technology in the healthcare field and are proud to have them join the Soulbrain family," said Dr. ...
"AI-driven diagnostic tools such as the HemoScreen represent the next evolution of diagnostic technologies. Making this technology available at the point of care for hospitals, medical practices, pharmacies, private laboratories and research organizations can increase patient safety, reduce delays in receiving key diagnostic results, and support ...
MIP Diagnostics Ltd. is active in a number of fields including Human Healthcare, Oil and Gas and Research Reagents and sees this relationship as part of its continued expansion strategy in diagnostics where the benefits of MIPs allow for better solutions to be developed over previously existing technologies. The combination of Veravas’ sample preparation ...
Life Science Intelligence (LSI) is hosting the Emerging Medtech Summit February 18-20th, 2020 at The Ritz-Carlton in Laguna Niguel, CA. The event is drawing attendance from major medtech investors and strategics looking to partner with new medical device, diagnostic, digital health and other healthtech innovators. In addition to startup CEO presentations, the event will include panel discussions ...
Using Veravas’ proprietary sample prep technology in conjunction with Tymora’s extracellular vesicle enrichment technology, the partnership will focus on developing the world’s first diagnostic test for Alzheimer’s Disease (AD) from human plasma samples as an alternative to current cerebral spinal fluid (CSF) neuromarker testing. ...